Title:
COMPOUND SERVING AS KAT6 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/280182
Kind Code:
A1
Abstract:
Provided in the present invention is a compound serving as a KAT6 inhibitor. Specifically, provided in the present invention is a compound having a structure as represented by the following formula (I) and formula (XIV), or an optical isomer, a pharmaceutically acceptable salt, a prodrug, a deuterated derivative, a hydrate or a solvate thereof. The compound can be used for treating or preventing diseases or conditions associated with the activity or expression level of KAT6.
Inventors:
ZHANG HANCHENG (CN)
JIA WEI (CN)
CAI CONGCONG (CN)
JIA WEI (CN)
CAI CONGCONG (CN)
Application Number:
PCT/CN2022/104005
Publication Date:
January 12, 2023
Filing Date:
July 05, 2022
Export Citation:
Assignee:
HANGZHOU INNOGATE PHARMA CO LTD (CN)
International Classes:
C07D413/02; A61K31/343; A61K31/41; A61K31/506; A61P35/00; A61P35/04; C07D413/06; C07D487/04
Domestic Patent References:
| WO2022013369A1 | 2022-01-20 | |||
| WO2020254946A1 | 2020-12-24 | |||
| WO2020216701A1 | 2020-10-29 | |||
| WO2020254946A1 | 2020-12-24 | |||
| WO2020216701A1 | 2020-10-29 | |||
| WO2013158004A1 | 2013-10-24 | |||
| WO2006610629A1 |
Foreign References:
| CN112334466A | 2021-02-05 | |||
| CN107098846A | 2017-08-29 |
Attorney, Agent or Firm:
XU&PARTNERS, LLC. (CN)
Download PDF: